get_clinical_trial_detail
按 trial_id + source 取试验详情。中文库给入组人数/评价指标/AI 摘要;全球库给入排标准与结局指标(长文按 4000 字截断)。
Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| source | No | cn 或 global,默认 cn | |
| trial_id | Yes | search_clinical_trials 返回的 id |
按 trial_id + source 取试验详情。中文库给入组人数/评价指标/AI 摘要;全球库给入排标准与结局指标(长文按 4000 字截断)。
| Name | Required | Description | Default |
|---|---|---|---|
| source | No | cn 或 global,默认 cn | |
| trial_id | Yes | search_clinical_trials 返回的 id |
Changes observed during successful MCP inspections.
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
No annotations are provided, so the description carries the full burden. It does disclose two useful non-schema behaviors: content varies by source, and long text is truncated at 4000 characters. However it says nothing about error behavior, missing-id handling, or the shape of the response beyond the content summary.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
Two dense sentences, zero filler. The core operation (fetch by trial_id + source) is front-loaded, followed by the per-source content contract and the truncation caveat.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
With no output schema, the description compensates by describing the returned content per source and the 4000-character truncation. For a two-parameter read tool with full schema coverage this is nearly complete; only error/edge-case behavior is unaddressed.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, so the baseline is 3. The description goes beyond the schema by explaining the semantic consequence of the 'source' parameter — which fields each database returns — rather than just repeating 'cn or global, default cn'.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
States a specific verb and resource ('取试验详情' / fetch trial detail) keyed by trial_id + source, and further specifies what the returned content is per source (cn: enrollment count, evaluation metrics, AI summary; global: eligibility criteria and outcome measures). This lets an agent distinguish it from search_clinical_trials without opening either schema.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
Usage is only implied: the schema's trial_id description points to ids returned by search_clinical_trials, so the search-then-detail flow is inferable. There is no explicit statement of when to use this versus alternatives, nor any prerequisite or exclusion guidance.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
Add one secure layer between your agents and this server.